Tradewinds, Llc. Bristol Myers Squibb CO Transaction History

Tradewinds, Llc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $199,157 - $262,194	4,948 New	4,948 $205,000
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $115 - $129	-2 Reduced 0.05%	4,008 $232,000
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $47,846 - $53,125	751 Added 23.04%	4,010 $256,000
Q1 2023 Apr 06, 2023	BUY	$65.71 - $74.53 $214,148 - $242,893	3,259 New	3,259 $225,000
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $5 - $2,996	39 Added 1.34%	2,943 $209,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $210,888 - $232,261	2,904 New	2,904 $224,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tradewinds, Llc., based on Form 13F filings with the SEC.

Stay updated on Tradewinds, Llc. with notifications on news.